Evidence map›Paper›PMID 31550237›Full record

ArticleThe Journal of clinical investigation2020

Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy.

Camille Piro-Mégy, Emmanuelle Sarzi, Aleix Tarrés-Solé, Marie Péquignot, Fenna Hensen, Mélanie Quilès, Gaël Manes, Arka Chakraborty, Audrey Sénéchal, Béatrice Bocquet and 15 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Exome Sequencing in a Large Cohort with Ciliopathy-Related Kidney Disease.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  7. Review
  8. Visual Function Characteristics inJournal of clinical medicine · 2025
    Article
  9. Article
  10. A case with bilateral C-shaped autofluorescence in retinal degeneration.American journal of ophthalmology case reports · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Discovery of novel disease-causing mutation inMolecular therapy. Nucleic acids · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 4 countries.

Camille Piro-MégyInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Emmanuelle SarziInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Aleix Tarrés-SoléStructural MitoLab, Department of Structural Biology, "Maria de Maeztu" Unit of Excellence, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, Spain.
Marie PéquignotInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Fenna HensenRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, Netherlands.
Mélanie QuilèsInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Gaël ManesInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Arka ChakrabortyStructural MitoLab, Department of Structural Biology, "Maria de Maeztu" Unit of Excellence, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, Spain.
Audrey SénéchalInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Béatrice BocquetInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Chantal CazevieilleInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Agathe RoubertieInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Agnès MüllerInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Majida CharifUMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
David GoudenègeUMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Guy LenaersUMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Helmut WilhelmUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Ulrich KellnerRare Retinal Disease Center, AugenZentrum Siegburg, MVZ Augenärztliches Diagnostik- und Therapiecentrum Siegburg GmbH, Siegburg, Germany.
Nicole WeisschuhInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Bernd WissingerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Xavier ZanlonghiCentre de Compétence Maladie Rares, Clinique Pluridisciplinaire Jules Verne, Nantes, France.
Christian HamelInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Johannes N SpelbrinkRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, Netherlands.
Maria SolaStructural MitoLab, Department of Structural Biology, "Maria de Maeztu" Unit of Excellence, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, Spain.
Cécile DelettreInstitute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Inserm · FRCentre National de la Recherche Scientifique · FRInstitut de Biologia Molecular de Barcelona · ESSTZ eyetrial · DERadboud University Nijmegen · NLClinique Jules Verne · FRHelios Hospital Siegburg · DE

Funding

Austrian Science Fund FWF I 2741
6 · The paper itself

Abstract

Mutations in genes encoding components of the mitochondrial DNA (mtDNA) replication machinery cause mtDNA depletion syndromes (MDSs), which associate ocular features with severe neurological syndromes. Here, we identified heterozygous missense mutations in single-strand binding protein 1 (SSBP1) in 5 unrelated families, leading to the R38Q and R107Q amino acid changes in the mitochondrial single-stranded DNA-binding protein, a crucial protein involved in mtDNA replication. All affected individuals presented optic atrophy, associated with foveopathy in half of the cases. To uncover the structural features underlying SSBP1 mutations, we determined a revised SSBP1 crystal structure. Structural analysis suggested that both mutations affect dimer interactions and presumably distort the DNA-binding region. Using patient fibroblasts, we validated that the R38Q variant destabilizes SSBP1 dimer/tetramer formation, affects mtDNA replication, and induces mtDNA depletion. Our study showing that mutations in SSBP1 cause a form of dominant optic atrophy frequently accompanied with foveopathy brings insights into mtDNA maintenance disorders.

Indexed as

Mutation, MissenseAdolescentAdultAgedAged, 80 and overChildDNA-Binding ProteinsDNA, MitochondrialDNA ReplicationExome SequencingFemaleGTP PhosphohydrolasesHumansMaleMiddle AgedMitochondrial ProteinsDNA-Binding ProteinsDNA, MitochondrialGTP PhosphohydrolasesMitochondrial ProteinsNABP2 protein, humanOPA1 protein, humanGeneticsMitochondriaNeurodegenerationOphthalmology

Identifiers

PMID31550237
PMCPMC6934222
OpenAlexW2976681362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.